|
AP-1 |
|
|
|
|
11216-028 |
AP-1 inhibitor Tanshinone IIA |
5 mg |
102 |
|
11216-029 |
c-Jun (human, recombinant) |
10 ΅g |
391 |
|
|
|
|
|
|
c-myc |
|
|
|
|
11216-059 |
Int-H1-S6A,F8A |
0.5 mg |
159 |
|
11216-060 |
H1-S6A,F8A |
0.5 mg |
82 |
|
11216-061 |
Anti-c-Myc antibody, clone 9E10 |
0.5 mg |
218 |
|
|
|
|
|
|
HIF |
|
|
|
|
11216-045 |
Amifostine |
10 mg |
87 |
|
11216-049 |
17-AAG |
1 mg |
206 |
|
11216-050 |
D609 |
5 mg |
90 |
|
11216-051 |
Dimethyl-bisphenol A |
10 mg |
94 |
|
11216-052 |
Geldanamycin |
1 mg |
107 |
|
11216-053 |
2-Methoxyestradiol |
10 mg |
87 |
|
11216-054 |
Vincristine Sulfate |
5 mg |
123 |
|
11216-055 |
Yc-1 |
5 mg |
102 |
|
11216-057 |
Anti-HIF-1alpha antibody, clone H167 |
250 ΅L |
473 |
|
11216-058 |
Anti-HIF-1alpha antibody, clone OZ12 |
100 ΅g |
414 |
|
|
|
|
|
|
NFkB |
|
|
|
|
11216-031 |
BAY 11-7082 |
10 mg |
96 |
|
11216-032 |
BAY 11-7085 |
10 mg |
96 |
|
11216-033 |
CAPE(Caffeic Acid Phenethylester |
20 mg |
94 |
|
11216-034 |
IKK-NBD Peptide |
0.5 mg |
159 |
|
11216-035 |
IKK-NBD Control Peptide |
0.5 mg |
159 |
|
11216-036 |
SN50, cell-permeable inhibitory peptide |
0.5 mg |
125 |
|
11216-037 |
SN50, cell-permeable inhibitory control peptide inhibitor |
0.5 mg |
125 |
|
11216-038 |
Parthenolide |
50 mg |
90 |
|
11216-039 |
Triptolide (PG490) |
1 mg |
111 |
|
11216-040 |
Wedelolactone |
1 mg |
118 |
|
11216-041 |
Lactacystin |
200 ΅g |
252 |
|
11216-042 |
MG-132 [Z-Leu-Leu-Leu-CHO] |
5 mg |
87 |
|
11216-043 |
SC-514 |
10 mg |
95 |
|
|
|
|
|
|
p53 |
|
|
|
|
11216-044 |
p53 Activator (Fusion Peptide 46), Cell Permeable |
0.5 mg |
206 |
|
11216-045 |
Amifostine |
10 mg |
87 |
|
11216-046 |
PRIMA-1 |
5 mg |
82 |
|
11216-047 |
Pifithrin-α |
5 mg |
90 |
|
11216-048 |
p53, His6-tagged (human, recombinant) protein |
20 ΅g |
363 |
|
|
|
|
|
|
PPAR |
|
|
|
|
11216-001 |
Bezafibrate |
1 g |
69 |
|
11216-002 |
Ciglitazone |
5 mg |
117 |
|
11216-003 |
Clofibrate |
1 g |
49 |
|
11216-004 |
ETYA |
20 mg |
87 |
|
11216-006 |
LY 171883 |
50 mg |
298 |
|
11216-007 |
Oleylethanolamide |
10 mg |
72 |
|
11216-008 |
15d-PGJ2 |
1 mg |
125 |
|
11216-009 |
Tetradecylthioacetic Acid |
10 mg |
82 |
|
11216-010 |
Troglitazone |
5 mg |
117 |
|
11216-011 |
WY-14643 |
50 mg |
102 |
|
11216-005 |
GW-9662 |
10 mg |
94 |
|
|
|
|
|
|
RXR |
|
|
|
|
11216-013 |
Acitretin |
10 mg |
125 |
|
11216-014 |
AM-580 |
5 mg |
107 |
|
11216-015 |
Geranylgeranoic Acid |
5 mg |
94 |
|
11216-016 |
4-Hydroxyphenylretinamide |
5 mg |
122 |
|
11216-017 |
Methoprene |
10 mg |
82 |
|
11216-018 |
Methoprene Acid |
5 mg |
102 |
|
11216-019 |
Retinoic Acid, all trans |
500 mg |
79 |
|
11216-020 |
9-cis Retinoic Acid |
5 mg |
125 |
|
11216-021 |
13-cis Retinoic Acid |
100 mg |
58 |
|
11216-022 |
TTNPB (Ro 13-7410) |
5 mg |
107 |
|
11216-023 |
Retinoid X Receptor β (RXRβ) hu rec. protein, part. pure |
50 ΅g |
182 |
|
11216-024 |
Anti-Retinoic Acid Receptor α (RARα), Mouse Mab |
50 ΅g |
414 |
|
11216-025 |
Anti-Retinoic Acid Receptor β (RARβ), Mouse Mab |
50 ΅g |
414 |
|
11216-026 |
Anti-Retinoic Acid Receptor γ 1 (RARγ1)rabbit antiserum |
100 ΅L |
414 |
|
11216-027 |
Anti-Retinoic X Receptor β (RXRβ), Mouse Mab |
25 ΅g |
154 |
+32 1658 9045
+32 1650 9045
